EMA clarifies biosimilar reference

EMA said biosimilar sponsors who use a reference product approved outside the EU must provide data from analytical studies showing an "acceptable bridge" between the biosimilar, the non-EU reference product and the EU-approved originator reference product. The detail came in (see BioCentury, July 9, 2012). ...